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Discussion
Dr V. Mohan Reddy. (Stanford, Calif). I would like to thank the
association for the privilege of discussing this manuscript. I would
also like to thank the authors for providing me with the manuscript
early enough and congratulate them for an elegant presentation and
study.
Dr Reemtsen and colleagues report on a 15-year single-institution
experience of neonatal Ebstein’s anomaly with an overall mortality of
25% but none since 1996. This approach commits all patients to
single—ventricle circulation. Probably some of these could have been
a 2-ventricle or a 1½-ventricle type of repair based on our experience
and review of the literature on neonatal Ebstein’s anomaly. It might be
that although this approach yields very good survival, a more bal-
anced individualized approach might yield similar results without
committing all patients to single-ventricle repairs.
In your manuscript, at least, I would say that 50% of the
patients have a GOS ratio of less than 1. Perhaps in these patients
a 2-ventricle or a 1½-ventricle type of repair could be attempted as
a first option.
Also, by means of right atrial reduction and RV plication, with
or without, the GOS ratio immediately decreases if you do a
postoperative study. But what is more important in your manu-
script is the long-term follow-up and continued remodeling of the
ventricle and the septum. This is, I think, the strength of your
study.
The authors state that these patients were all catheterized but do
not present any data on the catheterization. I have 4 or 5 questions
for you, and I would appreciate if you could answer each one of
them before I move on to the next.
Do you currently adopt this approach in all neonates or con-
sider 2-ventricle repair in some? If so, what criteria do you use?
Dr Reemtsen. Our goal, off the bat, is to establish a 2-ventricle
physiology, if possible, but I think that if you look at some of the
patients in our group, they have the massively dilated atrialized
portion of the right ventricle and really very little trabeculated right
ventricle. More to the point, the more significant thing is that they
really have a lack of functional tricuspid valve tissue altogether,
and therefore it is possible to do a repair, but I do not think you
would be doing the patient any favors.
Dr Reddy. So in the last 15 years, you have not attempted a
2-ventricle repair?
Dr Reemtsen. Actually, we have, and generally, these 2-
ventricle repairs are not in the neonatal time frame. We have had
3 total repairs during that time. We have had 1 death, 1 conversion
to the Starnes procedure, and 1 that was successful. The last patient
had the kind of tripartite ventricle that we would expect to perform
well.
Another and equally significant lesion we worry about is pul-
monary stenosis or atresia, which is commonly seen in neonates
with severe Ebstein’s anomaly. Because if you are doing a 2-
ventricle repair, again we are saying that you have leaflet tissue
that is not perfect, and then you also have RVOT obstruction. You
are going to put a small conduit in a neonate, and we know the
implications of that. Therefore in those patients especially, if they
have a ventricle that is kind of on the line and they have associated
pulmonary stenosis or atresia, we will go to the single-ventricle
approach.
Dr Reddy. You have catheterized most of the patients before
the Glenn and Fontan procedures. Do you have any information on
the end-diastolic pressure on these ventricles and the cardiac
index?
Dr Reemtsen. I have no specific numbers, but I actually looked
through this before I left. All of these patients who we have
observed thus far have been very good Fontan candidates, and we
expect that. Most of that is in part due to the normalization that we
see with the left ventricle.
Dr Reddy. I notice you do fenestrated patches in most of these,
and also from your manuscript I saw that when there is severe
pulmonary stenosis, you chose to entrap the pulmonary artery. But
in patients with antegrade flow, do you close this fenestration when
you do a Glenn or a Fontan procedure?
Dr Reemtsen. No, we leave the fenestration open. Really, we
only will interrupt the pulmonary artery if there is significant
regurgitation because we just want to keep the right ventricle
decompressed. That is the main goal. Therefore if there is ante-
grade flow and no regurgitation, we would leave that alone, but
that does not happen very often. As I said, the majority of these
patients have severe pulmonary stenosis or functional pulmonary
atresia.
Dr Reddy. The reason I ask that is that if you have antegrade
flow, you could close the fenestration. If you leave the fenestration
open, it is sort of acting like tracks for regurgitation or some sort
of regurgitation. Obviously you have regurgitation, and if you have
a single-ventricle type of physiology, any amount of regurgitation
probably is not a good idea in the long run anyway.
Dr Reemtsen. Well, the main point is that these are almost
nonfunctional right ventricles, and essentially, we just leave the
fenestration there in case there is any flow from the thebesian veins
because these are not normal ventricles. It is really a pop-off, and
the natural history is regression of this ventricle. Therefore we just
want to make sure that there is complete decompression, and that
is why we keep the fenestration patent.
Dr Reddy. That leads to my last question. You said that most
of these ventricles are nonfunctional and very small. Have you
noticed any thromboembolic phenomenon from this stasis?
Dr Reemtsen. We have not. We have not documented anything
like that.
Dr Reddy. Again, congratulations.
Dr Reemtsen. Thank you.
Dr Shunji Sano. (Okayama City, Japan). I have some com-
ments and questions. Septal impingement (SI ratio  a/b) in
echocardiographic analysis is actually the ratio to measure the
RV/LV pressure ratio, although this will become abnormal at the
time of volume overload. Therefore this does not help to measure
the volume load ratio in patients with Ebstein’s anomaly.
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Recovery of LV function, recovering after the RV exclusion, is
mostly based on the normalization of the intraventricular septum.
The LV end-diastolic and end-systolic dimensions that we can
measure became enlarged soon after the RV exclusion because of
the changes of ventricular septal motion. This phenomenon is seen
in patients with atrial septal defects with a huge Qp/Qp ratio. These
are all due to geometric changes.
Another thing is that in your slides the CT ratios and also the
echocardiograms show the improvement of ventricular LV motion,
and also the CT ratio decreased before the Glenn procedure. From
my experience of RV exclusion operations, when you excise the
LV free wall to decrease RV volume, intraventricular septal mo-
tion changed to normal from a paradoxical value soon after the RV
exclusion, and the CT ratio also decreased soon after. Therefore
another question is this: in the Starnes operation, without a com-
plete right LV exclusion, when do these findings, such as IVS
motion and CT ratio change, occur, soon after the operation or a
few months later?
Dr Reemtsen. No, I think it is certainly not immediate. Essen-
tially, after we perform this procedure, sometimes they have pul-
monary vascular twitchiness, and I think that is in response to their
LV failure. Usually we have to keep them on nitric oxide for a
couple of days to try and ameliorate that. Therefore I think it is
more than a week’s time.
However, you can notice, as Dr Reddy said, that as soon as you
do this resection, the GOS ratio should decrease. But looking at
x-ray films immediately postoperatively, it is not as marked, and it
is not even close to as marked as we see at the time of the Glenn
procedure. Therefore I think there is an immediate improvement
over a week-long postoperative period, and I think we have clearly
shown that there is continued improvement or regression and
normalization of the function of the left ventricle.
Dr Sano. I must inform you that from our experience, the RV
size decreased because our aim was to decrease RV size to excise
the RV free wall, but before the Glenn procedure, the right ven-
tricle increased again. Therefore it is almost similar to your echo-
cardiographic findings. Therefore we excise the RV free wall again
in few patients when the right ventricle increased again. I do not
know whether it is due to direct anastomosis of the RV free wall
after we excised the RV free wall or not. I wonder if I excise the
RV free wall and put a small polytetrafluoroethylene patch,
whether the right ventricle will increase in size or not. I do not
know.
Dr Reemtsen. I should not ask you a question, but did you
have any pulmonary atresia? Did you have a conduit in place or
anything like that that would kind of be the substrate for this kind
of redilation of your right ventricle?
Dr Sano. Yes, we have patients with true pulmonary atresia.
No, we have not used a conduit.
Dr Reemtsen. That would be an issue.
Dr Joseph A. Dearani. (Rochester, Minn). I would just like to
make one comment in follow-up to Dr Reddy’s comment about
this dilemma and trying to decide on a single-ventricle pathway or
biventricular repair in the neonatal period. One piece of informa-
tion that I will share with you that will be presented in our
Ebstein’s anomaly presentation tomorrow is that anatomic obstruc-
tion at the RV outflow level or the pulmonary valve level is an
independent predictor for mortality in late reoperation in a very
large number of patients with Ebstein’s anomaly. Consequently, if
an anatomic obstructive lesion in the RVOT or the pulmonary
valve level is demonstrated in the neonate, then we believe the
single-ventricle pathway is preferred.
Dr Reemtsen. And I can tell you from our experience that we
had 3 patients in this series, not of the RV exclusion, but all of the
neonates who underwent intervention, and every patient who had
a homograft placement as a neonate was either an early or late
death. Therefore we observed 100% mortality with placement of
conduits in the neonates.
Dr William J. Brawn. (Birmingham, United Kingdom). Is it
the shunt that saves the neonate’s life? Is that the essential part of
the operation?
Dr Reemtsen. No, it is not. We have a great example of a
patient who came with this problem last year, and we just did a
shunt first. The patient struggled along with persistent need for not
only inotropes but also ventilatory support for 2 weeks. We went
in and revised him to the Starnes procedure, and the kid was off the
vent within a few days. Therefore I think it is not only the
pulmonary blood flow issue, it is this interventricular relationship
and this dilation that you need to ameliorate.
Dr Glen Van Arsdell. (Toronto, Ontario, Canada). I hesitate
to even discuss this because the results are so good, but one of the
things this does is it forces you to make a decision early on as to
whether it is a 2-ventricle or single-ventricle repair. We have taken
an alternative approach of saying the primary issue is that there is
high PVR in the ductus in many of these kids staying open and let
us ligate the duct, let us alkalinize them and start them on nitric
oxide. Obviously that only works when it is functional pulmonary
atresia. Therefore I wonder whether you have explored that possi-
bility. These patients who are labeled as having atresia, I know you
have tried to classify them. Have you proved actual atresia, or is it
echocardiographic atresia that only looks that way because you have
high pulmonary artery pressures related to a duct that is open?
Dr Reemtsen. No, it is significant pulmonary stenosis, and
almost all of them have pulmonary stenosis of some sort. How-
ever, the amount of pulmonary atresia was more than half the
patients that we said had actual pulmonary atresia.
Dr Van Arsdell. Therefore for those patients, this is clearly a
very good strategy.
The question, I guess, is this: For the other patients, can you go
with a high PVR route and buy some time, maybe you buy them
a year or 2 or 3 before you have to make the next decision?
Dr Reemtsen. We would certainly attempt that first. There is
no question that we would-we always attempt to treat these pa-
tients medically first. It is not a kind of whisk off to the operating
room once we have this diagnosis, but our goal would really be to
get these patients out and not operate on them.
Dr Van Arsdell. But I mean specifically including duct ligation
as part of a strategy and alkalinization and nitric oxide?
Dr Reemtsen. Certainly.
Dr George R. Daicoff. (St Petersburg, Fla). A number of years
ago, I had a neonate such as you have presented, and when I
reviewed the literature, there was a 100% mortality rate in this
group. The heart was so huge. The lungs were hypoplastic and
underdeveloped. The baby was on a ventilator. A review of the
literature was not helpful with this desperate neonate, which led
me to confer with Gordon Danielson, who had a large series of
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patients with Epstein’s anomaly. He said that they did not have any
neonates in their Mayo Clinic practice.
Therefore I took the baby to the operating room prepared to do
an intracardiac procedure. The right atrium and right ventricle
were both huge, filling the thorax. The tricuspid regurgitation was
massive. In evaluating the tricuspid before cannulating for bypass,
I inverted the free wall of the right atrium through the tricuspid
annulus into the right ventricle. The tricuspid regurgitation became
a lot less, if not eliminated completely. Furthermore, this maneuver
decompressed and diminished the size of both right-sided cham-
bers. It occurred to me that I could reproduce this situation with
one stitch. Therefore I took a double-armed, pledgeted, plicating
stitch through the anterior wall of the right ventricle; dodged my
finger; and brought needles through the free wall of the right
atrium and a second pledget. Tying the stitch brought the right
atrium into the right ventricle. A modified BT shunt was done
at the same time. He did amazingly well and subsequently under-
went the Fontan operation. No cutting, no sewing; it was an easy
operation. I could not believe it.
Therefore the question I have for you is this: If I could do this
in the way I did, and probably obliterate the chamber, why do you
need a fenestration at all?
Dr Reemtsen. Well, I think the fenestration really comes into
account when you have what we are talking about: functional or
true pulmonary atresia because the ventricle needs some outflow.
I do not know about the patient that you had, if he or she had
pulmonary atresia, and it sounds to me like he or she did not. If
there is antegrade flow, the fenestration specifically might not be
necessary.
Dr Daicoff. That BT shunt was for that purpose, right?
Dr Reemtsen. What purpose is that? I am sorry?
Dr Daicoff. To give the pulmonary blood flow.
Dr Reemtsen. Yes, I agree. What I am saying though is that if
you have antegrade flow from out of the pulmonary valve, it will
decompress this ventricle and you will not need the fenestration. If
you have pulmonary atresia and you essentially occlude the right
ventricle with thebesian flow, it is likely that this is going to dilate.
Therefore that is the issue.
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